LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that Company management will be presenting at the 9th annual LD Micro Main Event on Wednesday, December 7th at 12:00 PM PST (3:00 PM EST) at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Jennifer K. Simpson, Ph.D., MSN, CRNP, President and Chief Executive Officer of Delcath, will be presenting a corporate overview, as well as meeting with investors.
The LD Micro Main Event is the largest independent conference for small/microcap companies and will feature 240 presenting names.
